Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $8.2M | $10.7M | $0 |
| Cost of revenue | $0 | $0 | $2.0M | $2.5M | $0 |
| Gross profit | $0 | $0 | $6.1M | $8.2M | $0 |
| Gross margin | — | — | 75.1% | 76.8% | — |
| R&D | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$1.8K | −$1.1M | −$10.3M | −$15.5M | −$972.2K |
| EBITDA | −$1.8K | $0 | −$9.0M | $3.0M | −$972.2K |
| Net income | −$1.8K | −$125.8K | −$15.9M | −$25.9K | $1.4M |
| Net margin | — | — | -195.3% | -0.2% | — |
| EPS (diluted) | -0.00 | -0.01 | -2.17 | -0.00 | 0.14 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds FGMCW.
No tracked institution reports a position in FGMCW as of their last filing.
No one on the platform has traded FGMCW yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.